Skip to main content
NewslettersWatchlist

Ideaya Biosciences Inc(IDYA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma

PR Newswire - Tue May 16, 2023

SOUTH SAN FRANCISCO, Calif., May 16, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has amended its clinical trial collaboration and supply agreements with Pfizer Inc. (NYSE: PFE) to support evaluation of darovasertib and crizotinib combination therapy in the company's planned Phase 2/3 registrational clinical trial in MUM and to continue support of the company's ongoing Phase 2 clinical trial in MUM.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

energy and resources
How Devon Energy missed out on the U.S. oil and gas mega-deal wave
FILE PHOTO: A pump jack operates at a well site leased by Devon Energy Production Company near Guthrie, Oklahoma September 15, 2015. Picture taken September 15, 2015. REUTERS/Nick Oxford/File Photo
market news
The close: Resource shares lift TSX ahead of jobs reports
A specialist trader works at his post on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 3.
inside the market
What every Canadian investor needs to know today
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 3, 2024. REUTERS/Brendan McDermid
investor newsletter
Finally, there’s good reason to get bullish on dividend stocks. Plus, what investors should do before capital gains taxes go up
Investing in dividend stocks doesn't have to mean avoiding growth stocks, but where can you find a dividend and value in the same place? Chris Raper, senior vice president and senior portfolio manager, Chris Raper & Associates of Raymond Mames gives his top 3 picks for value investors looking for a steady dividend payer.
globe investor
Nvidia overtakes Apple as No. 2 most valuable company
A person walks pass a Nvidia logo at Computex in Taipei, Taiwan June 5, 2024.
market news
The close: S&P 500 and Nasdaq hit fresh record highs, TSX advances after BoC rate cut
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
inside the market
What every Canadian investor needs to know today
NEW YORK, NEW YORK - JUNE 03: Traders work on the floor of the New York Stock Exchange during afternoon trading on June 03, 2024 in New York City. Stocks closed mixed on the first day of trading in June a day that started with a technical issue that was resolved that brought trading to a stop for some of the major stocks and caused Berkshire Hathaway to be down 99.97%. (Photo by Michael M. Santiago/Getty Images)
market news
The close: TSX hits six-day low but Wall Street slightly higher after weak job-openings data
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).